Meanwhile, administration of thymol increased p21expression in bladder cancer cells (Li et al., 2017) and increased expression of both p53 and p21 in breast cancer cells (Seresht et al., 2019). This evidence concerns the gene TP53 and urinary bladder carcinoma.